v3.19.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 8,224,801 $ 16,522,729
Accounts receivable, net 6,000,783 4,514,333
Inventory 2,595,095 1,068,557
Prepaid expenses and other current assets 1,018,689 919,500
Total current assets 17,839,368 23,025,119
Property and equipment, net 1,367,940 1,777,302
Total assets 19,207,308 24,802,421
Current liabilities:    
Accounts payable 2,634,279 1,351,736
Accrued expenses 3,432,001 2,900,129
Deferred revenue 417,891 270,998
Line of credit 953,094 0
Total current liabilities 7,437,265 4,522,863
Long-term debt 18,777,356 9,029,374
Long-term deferred revenue 224,088 304,467
Other non-current liabilities 147,115 808,366
Total liabilities 26,585,824 14,665,070
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit):    
Common stock, $0.0001 par value, 200,000,000 and 200,000,000 shares authorized at September 30, 2019 and December 31, 2018, respectively; 10,897,522 and 10,055,072 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively 1,088 1,004
Additional paid-in capital 87,297,299 82,898,775
Accumulated deficit (94,676,903) (72,762,428)
Total stockholders’ equity (deficit) (7,378,516) 10,137,351
Total liabilities and stockholders’ equity (deficit) $ 19,207,308 $ 24,802,421